Sanity Group is leading a change in the perception and regulation of cannabis across Europe. Centering on the untapped potential of cannabinoids for health, the company based in Berlin is bridging historical misconceptions with modern recognition of cannabis’s benefits.

Dual Approach: Medical Research And Consumer Wellness

Sanity Group tackles its mission from two angles: pushing the boundaries in medical cannabis research and elevating consumer wellness.

Their medical arm is pioneering in the realm of cannabis-based pharmaceuticals, with ambitions to become a top authority in European medical cannabis. Simultaneously, their consumer division is redefining wellness, introducing a range of products for a health-aware audience, and demonstrating the broad applications of non-psychoactive cannabinoids.

Educational Efforts To Reshape Views

A persistent hurdle in cannabis acceptance is its enduring stigma, which Sanity Group addresses directly. The company is committed to educational endeavors and advocacy, aiming to dismantle longstanding biases by underscoring cannabis’s diverse roles. The founder articulates this dedication on the company’s website:

“Unfortunately, Cannabis still has very often a negative stigma attached to it. We want to give the plant a new chance because what people associate with it is based on old prejudices. It’s important to us to actively contribute to education and knowledge transfer. This also involves showing decision-makers the differences between cannabis as a medicine, agricultural substance, and lifestyle product. It’s important to understand the full potential of the plant — that’s what we’re working for, to bring cannabis back to the center of European society.”

Finn Hänsel
Founder & Managing Director, Sanity Group

Groundbreaking Projects: Grashaus Initiatives

Sanity Group’s notable Grashaus Projects in Switzerland have led to the opening of Europe’s first legal cannabis store according to a recent press release.

This initiative, in collaboration with the Swiss Institute for Addiction and Health Research, transcends retail to become a comprehensive study of the impacts of regulated cannabis use. By providing a controlled setting for purchasing and learning about various cannabis products, Grashaus Projects signifies a progressive move towards informed cannabis policy in Europe.

Moving Forward

At the forefront of change, Sanity Group merges medical research with consumer wellness to unlock the full potential of cannabinoids. Through projects like Grashaus, Sanity Group is not only making quality cannabis products more accessible but also plays a pivotal role in reshaping cannabis policies and societal views, heralding an era where cannabis’s full potential is acknowledged for health and well-being enhancements across Europe.

The Benzinga Cannabis Capital Conference is returning to Florida in a new venue in Hollywood on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn, and grow.

Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars — this conference is the go-to event of the year for the cannabis world. Get your tickets now on bzcannabis.com – Prices will increase very soon!

Photo: Maximilian König for Sanity Group